CCL11 and Stroke: Western blot analysis on day 7 post-stroke in both adolescent (Supplementary Figure S2) and adult (Supplementary Figure S3) mice revealed no significant difference between CCL11-treated mice and controls, albeit protein abundance of cyclin-depended kinase 5 (CDK 5) was increased after CCL11 treatment in adult mice (Supplementary Figure S3).